Medscape

Professor, University Eminent Scholar and Director of Neurosciences - Stroke Center, Medical University of South Carolina, Charleston, South Carolina

Robert J. Adams, MS, MD, FAHA, has disclosed that he owns stock in ReachCom, Inc. Dr. Adams has also disclosed he has served as an advisor to Bristol-Myers Squibb Company, sanofi-aventis, Genentech, Inc., and Boehringer-Ingelheim Pharmaceuticals, Inc.

Professor of Neurology, Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Director, Stroke Program, Northwestern Memorial Hospital, Chicago, Illinois

Mark J. Alberts, MD, has disclosed he has served as a consultant to AGA Medical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Genentech, Inc., Kos Pharmaceuticals, Inc., Medicines Company, Merck & Co., Inc., Novo Nordisk, PDL BioPharma, Inc., Pfizer Inc., and sanofi-aventis. Dr. Alberts has also disclosed he has received research grants from AGA Medical, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., Novo Nordisk, Photo Thera, sanofi-aventis, and Schering-Plough Corporation. Dr. Alberts has also disclosed that he has served on the speakers bureaus of AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., diaDexus, Inc., Genentech, Inc., The Medicines Company, Medscape, Novo Nordisk, PDL BioPharma, Inc., and sanofi-aventis. Dr. Alberts has also disclosed that he has served on the advisory boards of AGA Medical, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Genentech, Inc., Kos Pharmaceuticals, Inc., The Medicines Company, Medscape, Novo Nordisk, Pfizer Inc., and sanofi-aventis. Dr. Alberts has disclosed he has served on the review panel of Mitisubishi Pharma America, TAP Pharmaceuticals (Data Safety Monitoring Board), and Schering-Plough Corporation. Dr. Alberts has received honoraria from AGA Medical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., diaDexus, Inc., Eli Lilly and Company, Genentech, Inc., Kos Pharmaceuticals, Inc., The Medicines Company, Medscape, Merck & Co., Inc., Novo Nordisk, PDL BioPharma, Inc., Pfizer Inc., sanofi-aventis, TAP Pharmaceuticals, and Schering-Plough Corporation. Dr. Alberts also received royalty from Duke University/Athena Diagnostics for an ApOE Genotype Test.

Pittsburgh Neurology Center, Pittsburgh, Pennsylvania

Neil A. Busis, MD, has disclosed no relevant financial relationships.

Associate Professor, University of Toledo Medical Center, Toledo, Ohio; Director, Center for Neurological Disorders, Department of Neurology, University of Toledo Medical Center, Toledo, Ohio

Lawrence W. Elmer, MD, PhD, has disclosed he has received honoraria or consulting fees from Boehringer-Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Teva Neuroscience, Inc., UCB Pharma, Inc., Valeant Pharmaceuticals International, and Vernalis. Dr. Elmer has disclosed that he has received grant support from GlaxoSmithKline.

Clinical Professor of Neurology, Weill Medical College of Cornell University; Chief of Neurology, Park Plaza Hospital; Clinical Professor, Family and Community Medicine, Baylor College of Medicine; Houston, Texas

Randolph W. Evans, MD, has disclosed that he has served as an advisor or consultant to Merck, Ortho-McNeil, Pfizer, and GlaxoSmithKline.

Professor of Neurology, University of Ottawa, Ottawa, Ontario, Canada; Director, Multiple Sclerosis Research Clinic, The Ottawa Hospital-General Campus, Ottawa, Ontario, Canada

Mark S. Freedman, MD, has disclosed that he has received honoraria Bayer HealthCare Pharmaceuticals, sanofi-aventis, Genentech, Inc., Biogen Idec Inc, Merck & Co, Inc., Serono, Novartis Pharmaceuticals Corporation, and Teva Neuroscience, Inc. Dr. Freedman has also disclosed he has served as an advisor or consultant to sanofi-aventis, Bayer HealthCare Pharmaceuticals, Eli Lilly and Company, Merck & Co., Inc., Serono, and Novartis Pharmaceuticals, Inc.

Professor of Alzheimer's Research; Associate Director, Alzheimer's Disease Research Center; Professor of Psychiatry and Neurology, Mount Sinai School of Medicine, New York, New York

Samuel E. Gandy, MD, PhD, has disclosed he has served as an advisor or consultant to Amicus, Epix, Diagenic, Wyeth Pharmaceuticals Inc., and Elan Pharmaceuticals, Inc. Dr. Gandy has also disclosed he has received grants for educational activities from Forest Laboratories, Inc.

Professor of Neurology, Genetics and Epidemiology, Co-Director, Alzheimer's Disease Clinical & Research Program, Boston University, Boston, Massachusetts

: Robert C. Green, MD, MPH, has disclosed that he has received grants for educational activities from Myriad Pharaceuticals.

Professor and Chairman, Department of Neurology, University of Heidelberg, Heidelberg, Germany

Werner Hacke, MD, PhD, has disclosed that he has served as an advisor or consultant to Boehringer-Ingelheim Pharmaceuticals, Inc., sanofi-aventis, Novothesa, and Brainsgate.

Professor of Neurological Sciences, Rush Medical College, Rush University Medical Center, Chicago, Illinois

Andres M. Kanner, MD, has disclosed that he has received research grants from GlaxoSmithKline, and Novartis Pharmaceuticals Corporation. Dr. Kanner has also disclosed that he has served on the advisory boards of GlaxoSmithKline, UCB Pharma, Inc., and Ortho-McNeil, Inc. Dr. Kanner has also disclosed he has served on the speakers bureaus of GlaxoSmithKline, UCB Pharma Inc., Pfizer, Inc., and Ortho-McNeil, Inc.

Professor, Chair of Neurologic Surgery, University of California Davis, Sacramento, California

Jan Paul Muizelaar, MD, PhD, has disclosed no relevant financial relationships.

Chairman, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York; Professor, Anesthesiology and Neurology, Albert Einstein College of Medicine, New York, New York

Russell K. Portenoy, MD, has disclosed that he has been a compensated consultant to Adolor, Alpharma, Ameritox, BiolineRx, Endo Pharmaceuticals, GW Pharma, INSYS Therapeutics, King Pharmaceuticals, Nektar Therapeutics, Neuromed, Shire Pharmaceuticals, Titan, Transcept Pharmaceuticals, Inc., WEX Pharmaceuticals, Inc., and Wyeth. Dr. Portenoy has also disclosed he has received educational and research grants to the department of Pain Medicine and Palliative Care from Abbott Laboratories, Archimedes Pharma, Ltd., Baxter HealthCare Corporation, Biovail Corporation, Calloway Labs, Cephalon, Inc., Elan Pharmaceuticals, Inc., Endo Pharmaceuticals, Fralex, GW Pharmaceuticals Inc., King Pharmaceuticals, Medtronic, Inc., Pfizer, Inc., Purdue Pharma LP, United BioSource Corporation, and Wyeth Pharmaceuticals.

Clinical Professor of Psychiatry, University of Michigan College of Medicine, Detroit, Michigan; Director, Sleep Disorder & Research Center, Henry Ford Hospital, Detroit, Michigan

Thomas Roth, PhD, has disclosed that he has received grants from sanofi-aventis, Cephalon, GlaxoSmithKline, Neurocrine, Pfizer, Schering-Plough, Sepracor, Somaxon, Syrex, Takeda, TransOral, Wyeth, and Xenoport. Dr. Roth has also disclosed he has served as a speaker for Cephalon, sanofi-aventis, and Takeda. Dr. Roth has also disclosed he has served as a consultant to Abbott, Actelion, Arena, sanofi-aventis, BTG, Cephalon, Evotech, Intec, Intra-Cellular, Jazz, Merck, @Neurim, Neurocrine, Neurogen, Organon, Proctor & Gamble, Pfizer, Sepracor, Shire, Somaxon, Takeda, TransOral, and Vanda.

Clinical Professor of Neurology, University of Minnesota, Minneapolis, Minnesota

Randall T. Schapiro, MD, has disclosed that he has received grants for educational activities from Teva Neuroscience, Inc., Biogen Idec., Inc., Serono, Pfizer, Inc., Bayer HealthCare Pharmaceuticals, and Acorda. Dr. Schapiro has also disclosed that he has served as an advisor or consultant to Serono, and Acorda.

Professor of Neurology; Director, Movement Disorders Program, Medical College of Georgia, Augusta, Georgia

Kapil D. Sethi, MD, has disclosed that he has served as an advisor or consultant to and received grants for clinical research from Boehringer Ingleheim Pharmaceuticals, Inc., Schering-Plough Corporation, GlaxoSmithKline, Allergan, Inc., Novartis Pharmaceuticals Corporation, and Solvay. Dr. Sethi has also disclosed that he owns stock, stock options or bonds and has received grants for educational activities from Pfizer, Inc. and Elan Pharmaceuticals.

Stephen D. Silberstein, MD, Director, Headache Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania; Professor Of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania

Stephen D. Silberstein, MD, has disclosed that he is on the advisory panel, speakers bureau or serves as a consultant for AGA, Allergan, Capnia, Endo Pharmaceuticals, GlaxoSmithKline, MAP, Medtronic, Merck, NuPathe, Pfizer, Valeant Pharmaceuticals, and Vyteris. Dr. Silberstein has also disclosed he receives research support from AGA., Advanced NeuroModulation Systems, Allergan, Boston Scientific, Coherex, Endo Pharmaceuticals, GlaxoSmithKline, Lilly, MAP, Medtronic, Merck, NuPathe, and Valeant Pharmaceuticals.

Professor of Neurology, Albert Einstein College of Medicine, Bronx, New York; Director, Sleep Wake Disorder Center, Department of Neurology, Montefiore Medical Center, Bronx, New York

Michael Thorpy, MD, has disclosed that he has served on the speaker's bureau and has served as a consultant to Cephalon, sanofi-aventis, GlaxoSmithKline, and Jazz Pharmaceuticals. Dr. Thorpy has also disclosed that he has served as a consultant to and received research grants from Neurogen.